Articles published by Aptevo Therapeutics
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Aptevo Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
May 12, 2022
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
APVO442 Prostate Cancer Data Presented at the American Association for Cancer Research Annual Meeting
April 12, 2022
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Aptevo Therapeutics Earns $10 Million Non-Dilutive Milestone Payment on Sales of RUXIENCE, Provides Company Update
February 09, 2022
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Aptevo Therapeutics' Board Chairman, Fuad El-Hibri, Announces Retirement, Effective April 1, 2022
January 21, 2022
From Aptevo Therapeutics
Via AccessWire
Topics
Retirement
Exposures
Pension
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal, "Nature Communication"
December 15, 2021
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Aptevo Therapeutics Announces the Presentation of Two Abstracts at the Upcoming American Society of Hematology Annual Meeting
November 15, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
November 12, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Alligator Bioscience and Aptevo Therapeutics Announce a Poster Presentation of ALG.APV-527 at SITC Annual Meeting 2021
November 11, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Aptevo Therapeutics Announces Preclinical Data for Bispecific Antibody APVO603 at the Society for Immunology in Cancer Annual Meeting
November 11, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Aptevo Therapeutics Announces Publication of a Scientific Article in Peer-Reviewed Journal, Frontiers in Aging
September 28, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Aptevo Therapeutics Announces APVO436 Monotherapy is Active in Patients Who Have Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome
August 17, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Aptevo Therapeutics Reports Second Quarter Financial Results with Business Highlights
August 12, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Tickers
APVO
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting
April 09, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Tickers
APVO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.